|
|
Imaging the Acute & Critical Patient
Expedient and accurate radiologic triage is paramount in formulating treatment plans in time-sensitive scenarios, whether a patient presenting with an acute abdomen, acute stroke or the deteriorating patient in the ICU. Treatment paradigms rely heavily if not exclusively on the radiologist’s interpretation. Our distinguished faculty will provide a variety of didactic lectures and case-based presentations with disease-specific approach that includes musculoskeletal, GI/GU, chest, body, pediat... |
|
|
Update in Food Allergy Management
Target Audience
This activity has been designed to address the educational needs of pediatric nurse practitioners, pediatricians, and allergists. It may also benefit other clinicians interested in the management of food allergy (FA).
Program Overview
New insights into the immunopathology of FA have led to development of cautious use of controlled exposure to food allergens through allergen immunotherapy and emerging use of monoclonal antibody therapy to interfere with the synthesis of imm... |
|
|
Can You Compete? Best Practices for Nonadvanced Systemic Mastocytosis
Don’t miss this Medical Jeopardy activity, designed to provide an informative, unique, and engaging educational approach to learning about nonadvanced systemic mastocytosis (SM)! Learners will watch a modified “Jeopardy” game, and each team will be led by our expert faculty contestants, with the didactic content presented as an explanation of the correct answer to each question. Topics covered will include pathophysiology, diagnosis, treatment paradigms, including the use of tyrosine kin... |
|
|
Psoriasis Prime Time: The Role of TYK Inhibition in Psoriasis
Target Audience
This activity has been designed to address the educational needs of dermatologists, dermatology nurse practitioners, and PAs. It may also be of benefit to primary care clinicians, rheumatologists, and other healthcare practitioners who are interested in the treatment of psoriasis.
Program Overview
In this edition of Psoriasis Prime Time, the faculty reviews the unique mechanism of action for allosteric tyrosine kinase 2 (TYK2) inhibitors compared with Janus kinase inhibito... |
|
|
Distinguishing and Managing Early-Stage Alzheimer’s Disease (AD): Leveraging Interdisciplinary Collaboration for Prompt Identification and Optimal Patient Management
Target Audience
This activity is designed to meet the educational needs of healthcare providers involved in the diagnosis and continued care of patients with Alzheimer’s disease, including neurologists, geriatricians, psychiatrists, primary care physicians, nurses, and other multidisciplinary team members.
Program Overview
This educational activity is designed to provide clinicians who manage patients with Alzheimer’s disease with current information on diagnosis and management, inclu... |
|
|
Treating Obesity 2025: The Blackburn Course in Obesity Medicine - LIVE STREAMING
Education to Optimize Your Care of Adult, Adolescent, and Pediatric Patients with Obesity
This highly rated Harvard Medical School CME course delivers practical strategies to optimize the management of obesity and its many complications, and provides the most up-to-date approaches to obesity prevention and treatment.
Highlights of the 2025 program include:
• Update on using the newer GLP-1 based therapies
• Comprehensive evaluation of the patient with obesity
• Precision medicin... |
|
|
PEERx - Ethics Module 1: Priority of Pharmacy Ethics in Healthcare
This Educational Activity is provided by Pharmacy Ethics, Education, and Resources (PEER) and is designed to educate healthcare professionals on ethics to improve patient safety.
Ethics is a top priority in pharmacy across all practice areas. It is essential for pharmacy staff to grasp the ethical principles endorsed by pharmacy leadership. Through discussing ethics and learning from historical incidents in pharmacy involving ethical violations, pharmacy professionals can proactively pre... |
|
|
PEERx - Ethics Module 3: Importance of Business Ethics to the Pharmacy Community
This Educational Activity is provided by Pharmacy Ethics, Education, and Resources (PEER) and is designed to educate healthcare professionals on ethics to improve patient safety.
Pharmacy presents its own set of challenges. When business is intertwined, it gives rise to numerous ethical dilemmas. This program aims to introduce the ethical principles within the pharmacy and business realms, as well as to outline a robust decision-making framework. By reviewing various scenarios, owners, s... |
|
|
PEERx - Ethics Module 2: Evolution of Healthcare Ethics
This Educational Activity is provided by Pharmacy Ethics, Education, and Resources (PEER) and is designed to educate healthcare professionals on ethics to improve patient safety.
The healthcare landscape is rapidly evolving, requiring healthcare professionals to adapt accordingly. Having effective decision-making strategies is crucial for making ethical choices in current situations and future possibilities. Practicing these strategies in a calm setting can help professionals make sound ... |
|
|
PEERx - Ethics Module 6: Preparing Pharmacy For The Next Crisis
This Educational Activity is provided by Pharmacy Ethics, Education, and Resources (PEER) and is designed to educate healthcare professionals on ethics to improve patient safety.
The emergence of the COVID-19 virus in 2020 plunged the world into an unprecedented pandemic. Pharmacists found themselves at the forefront of this global health emergency, facing it with minimal preparation and guidance. With existing emergency plans proving ineffective during a worldwide shutdown, this initiat... |
|
|
Psoriasis With Scalp Involvement in a Patient With Skin of Color
Target Audience
This activity has been designed to address the educational needs of dermatologists, dermatology nurse practitioners, and PAs. It may also be of benefit to primary care clinicians, rheumatologists, and other healthcare practitioners who are interested in the treatment of psoriasis.
Program Overview
This case will discuss the treatment of psoriasis in patients with skin of color, highlighting the challenges of treating scalp psoriasis. The faculty will review the mechanism o... |
|
|
Psoriasis Prime Time: TYK Inhibition in Hard-to-Treat Psoriasis
Target Audience
This activity has been designed to address the educational needs of dermatologists, dermatology nurse practitioners, and PAs. It may also be of benefit to primary care clinicians, rheumatologists, and other healthcare practitioners who are interested in the treatment of psoriasis.
Program Overview
In this edition of Psoriasis Prime Time, the faculty reviews the use of allosteric tyrosine kinase 2 (TYK2) inhibitors in the treatment of hard-to-treat psoriasis, including the ... |
|
|
Establishing Frameworks for Precision Medicine in NTRK Fusion-Positive Advanced Solid Tumors
Despite significant advancements over the past decade, significant unmet needs persist for patients with NTRK-positive locally advanced or metastatic solid tumors. In addition, there is ongoing debate about the importance of testing for genomic alterations in rare cancers, or those that rarely occur in common cancers. However, evolving molecular testing procedures and emerging therapeutic options targeting NTRK fusions offer new pathways for the detection and treatment of these cancers. To he... |
|
|
ASCVD Clinical Research Updates Targeting Residual Inflammation in Patients with ASCVD and CKD
Emerging evidence and scientific advancements are revealing pathophysiologic mechanisms correlated with systemic inflammation and the development of atherosclerotic cardiovascular disease (ASCVD). Patients with chronic kidney disease (CKD) are at high risk for developing ASCVD. Novel anti-inflammatory therapies are showing efficacy at reducing inflammation and development of ASCVD, and are adding to the treatment options beyond the usual lipid-lowering agents. As new clinical evidence and tar... |
|
|
Treating SCLC in the Relapsed/Refractory Setting: Giving Patients a Voice About Second-Line Therapy
SCLC is aggressive in nature with a high recurrence rate following initial treatment and a propensity to become resistant to conventional therapies. Early detection is critical, but many patients are diagnosed at an advanced stage where prognosis is poor. Progress in the second-line setting offers new hope for improving patient outcomes, but the rapid pace at which these advances are occurring present challenges for effectively integrating novel therapies into patient care. In fact, research s... |
|
|
Inherited Retinal Diseases: Navigating the Future of Diagnostics and Emerging Therapies
The differential diagnosis and workup of a suspected inherited retinal disease (IRD) can be challenging, requiring the expertise of the multidisciplinary healthcare team. Guidelines released in 2022 by the American Academy of Ophthalmology provide recommendations and clinical genetic assessments for patients with IRDs. Genetic counseling is essential to help patients understand the genetic test results, their implications for prognosis, family planning, and therapeutic decisions. Genetic testi... |
|
|
Thyroid Eye Disease: Unmasking and Taming What’s in Disguise
Thyroid eye disease (TED) is a complex autoimmune-mediated inflammatory disorder of the orbit that is associated with a spectrum of signs and symptoms and varying levels of severity. Early diagnosis and initiation of appropriate treatment are imperative for preventing progression to severe disease and potential vision loss. However, diagnosis can be challenging. Traditional treatments for TED, such as steroids, radiotherapy, and surgery, all relieve symptoms but do not alter the course of dise... |
|
|
HER3 in NSCLC " Navigating New Frontiers in Targeted Therapy
In patients with non-small cell lung cancer (NSCLC), human epidermal growth factor receptor 3 (HER3) is associated with both advanced disease and resistance to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)"directed therapies. Although there are therapeutic options targeting EGFR (HER1) and HER2, the potential of HER3 as an anti-cancer target has been largely overlooked. Overexpression of HER3 in most patients with NSCLC positions it as an appealing therapeutic targ... |
|
|
Formalized Training Cascades for Pharmacy Teams: Becoming an LGBTQ+ Ally to Improve HPV Immunization
Health disparities faced by LGBTQ+ individuals include social stigma and discrimination that are associated with increased rates of mental health disorders, substance abuse, and suicide. Better understanding the health and wellbeing of LGBTQ+ people throughout their lives has been prioritized in research of late; however, a paucity of HCPs who are culturally competent in LGBTQ+ healthcare threatens to undermine improvement efforts.
Because pharmacists and pharmacy technicians provide access... |
|
|
In the Clinic: A Case-Based Discussion on Managing CSU
Target Audience
This activity has been designed to meet the educational needs of allergists, dermatologists, and primary care providers. It may also benefit nurse practitioners, PAs, and other clinicians who are interested in the management of patients with chronic spontaneous urticaria (CSU).
Program Overview
This engaging, sharply focused discussion between experts on CSU provides a case-based review of managing this troubling disease that can produce a diminished quality of life.
Le... |
|
|
Evolving Treatment Paradigms in HR+/HER2- Early Breast Cancer: Advancing Equitable Care in Rural and Underserved Communities
Target Audience
This activity is designed specifically for oncologists, advanced practice providers, and other members of the healthcare team who serve patients from rural and underserved communities.
Program Overview
Hormone receptor"positive, human epidermal growth factor receptor 2"negative (HR+/HER2-) breast cancer accounts for up to 70% of all breast cancer cases. In recent years, therapies such as CDK4/6 inhibitors, PARP inhibitors, and novel endocrine therapies have been ... |
|
|
Overcoming the Stigma of Mental Illness
Overcoming the Stigma of Mental Illness is a 2-hour online continuing education (CE/CEU) course that explores the stigmas around mental illness and provides effective strategies to overcome them.
The Substance Abuse and Mental Health Services Administration (SAMHSA) defines mental illness stigma as “a range of negative attitudes, beliefs, and behaviors about mental and substance use disorders.” Mental health and substance use disorders are prevalent and among the most highly stigmatized... |
|
|
The Suicide Survivor
The Suicide Survivor is a 2-hour online continuing education (CE) course that provides an understanding and means for helping the people who have lost loved ones to suicide.
One of the most difficult and complex emotional adjustments many individuals will ever face is the challenging and often lengthy process of dealing with the suicide of a family member or other loved one. These people are called suicide survivors; the family members and close friends who have experienced the death of a f... |
|
|
Therapy Tidbits – May/June 2019
Therapy Tidbits – May/June 2019 is a 1-hour online continuing education (CE) course comprised of select articles from the May/June 2019 issue of The National Psychologist, a private, independent bi-monthly newspaper intended to keep psychologists informed about practice issues. The articles included in this course are:
Psychologists Face Denials, Delays in Testing Payments - Discusses the difficulties of receiving reimbursement following the update of Current Procedural Terminology (CPT) ... |
|
|
COVID-19: Picking Up the Pieces
COVID-19: Picking Up the Pieces is a 2-hour online continuing education (CE) course that examines the effects of the pandemic and the challenges we face moving forward.
This course will discuss the many aspects of COVID-19 that have affected us all, physically, psychologically, and economically. It will begin with a discussion of what pandemics are, and what differentiates COVID-19 from previous pandemics. We will then turn our attention to the psychological effects of a pandemic – from a... |
|
|
Therapy Tidbits – Spring 2021
Therapy Tidbits – Spring 2021 is a 1-hour online continuing education (CE) course comprised of select articles from the Winter 2021 issue of The National Psychologist, a private, independent, quarterly newspaper intended to keep psychologists informed about practice issues. The articles included in this course are:
Congress Throws a Wrench in Medicare Telehealth Rules – Identifies Section 123 of the Consolidated Appropriations Act and explains the impact this bill will have on telehealt... |
|
|
HIV/AIDS: Adherence Issues
HIV/AIDS: Adherence Issues is a 1-hour online continuing education (CE) course that discusses adherence issues in populations at high risk for HIV infection.
HIV and AIDS are medical terms that are linked together due to the progressive nature of HIV. When untreated or undertreated, HIV will become AIDS. The virus can affect people of all ages " children who are born to mothers who have HIV, adolescents, adults, and elders. People who are diagnosed with HIV can live almost normal lifes... |
|
|
Ethics & Risk Management: Expert Tips 10
Ethics & Risk Management: Expert Tips 10 is a 3-hour online continuing education (CE) course that addresses a variety of ethics and risk management topics in the form of 26 short articles, written by experts in the field. Topics include:
What Happens Next? Confidentiality after Death - Considers the legal and ethical issues of sharing confidential client records after a patient’s death.
Out-of-Office Encounters May Be Beneficial - Discusses the importance and benefits of out-of-office th... |
|
|
The Impact of a Life of ADHD: Understanding for Clinicians and Clients
The Impact of a Life of ADHD: Understanding for Clinicians and Clients is a 3-hour online continuing education (CE) course that highlights the ways in which ADHD impacts every aspect of a person’s functioning and discusses the importance of educating clients and normalizing their difficulties as an aid to the treatment process.
This course is divided into two sections. Section 1 explores the direct affects and secondary outcomes of a lifetime of undiagnosed and untreated ADHD, followed by... |
|